scholarly journals Serum Levels of Soluble CD26/Dipeptidyl Peptidase-IV in Type 2 Diabetes Mellitus and Its Association with Metabolic Syndrome and Therapy with Antidiabetic Agents in Malaysian Subjects

PLoS ONE ◽  
2015 ◽  
Vol 10 (10) ◽  
pp. e0140618 ◽  
Author(s):  
Radwan H. Ahmed ◽  
Hasniza Zaman Huri ◽  
Zaid Al-Hamodi ◽  
Sameer D. Salem ◽  
Sekaran Muniandy
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Metabolic Syndrome ◽  
Type 2 Diabetes Mellitus ◽  
Serum Levels ◽  
Dipeptidyl Peptidase ◽  
Dipeptidyl Peptidase Iv ◽  
Antidiabetic Agents

Association between HbA1c and dipeptidyl peptidase IV activity in type 2 diabetes mellitus

2012 ◽  
Vol 413 (11-12) ◽  
pp. 1020-1021 ◽  
Author(s):  
Luziane Potrich Bellé ◽  
Paula Eliete Rodrigues Bitencourt ◽  
Karine Santos De Bona ◽  
Rafael Noal Moresco ◽  
Maria Beatriz Moretto
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Dipeptidyl Peptidase ◽  
Dipeptidyl Peptidase Iv

Sulfonamide-1,3,5-triazine–thiazoles: discovery of a novel class of antidiabetic agents via inhibition of DPP-4

RSC Advances ◽  
2016 ◽  
Vol 6 (86) ◽  
pp. 83438-83447 ◽  
Author(s):  
Hai-De Gao ◽  
Peng Liu ◽  
Yang Yang ◽  
Fang Gao
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Dipeptidyl Peptidase ◽  
Antidiabetic Drugs ◽  
Antidiabetic Agents ◽  
Dipeptidyl Peptidase 4

Dipeptidyl peptidase-4 (DPP-4) inhibitors are a novel class of antidiabetic drugs used for treating type 2 diabetes mellitus.

Sign in / Sign up

Export Citation Format

Share Document